PCDHB3: A Non-Coding RNA Molecule with Potential as A Drug Target and Biomarker

Target Name: PCDHB3

NCBI ID: G56132

PCDHB3: A Non-Coding RNA Molecule with Potential as A Drug Target and Biomarker

PCDHB3 (PCDH-BETA3) is a gene that encodes a protein known as PCDHB3. PCDHB3 is a non-coding RNA molecule that has been shown to play a role in the development and progression of various diseases, including cancer.

One of the key functions of PCDHB3 is its ability to act as a drug target. Many studies have shown that PCDHB3 can be targeted by small molecules, such as inhibitors, to induce apoptosis (programmed cell death) in cancer cells. These inhibitors can disrupt the activity of PCDHB3 and cause cancer cells to stop dividing and die.

Another function of PCDHB3 is its role as a biomarker. The expression of PCDHB3 has been shown to be associated with the development and progression of various diseases, including cancer. By measuring the levels of PCDHB3 in tissue samples or blood samples, researchers can monitor the effectiveness of treatments and track the progress of diseases.

In addition to its potential as a drug target and biomarker, PCDHB3 is also a promising candidate for future research into the regulation of cell growth and differentiation. Many scientists are currently investigating the mechanisms by which PCDHB3 regulates cell growth and are working to develop new treatments that target this protein.

Overall, PCDHB3 is a complex gene that has important functions in the regulation of cell growth and differentiation. Its potential as a drug target and biomarker make it an attractive target for future research into the development of new treatments for a variety of diseases.

Protein Name: Protocadherin Beta 3

Functions: Potential calcium-dependent cell-adhesion protein. May be involved in the establishment and maintenance of specific neuronal connections in the brain

More Common Targets